Ricerca Biosciences Expands into Preclinical Sector
Ian Lennox, chairman and CEO of Ricerca Biosciences, outlines the company's growth strategy post its acquisition of the discovery and preclinical business of MDS Pharma Services.
Time for a Model Upgrade
CMOs' business model has all of the flaws of the captive model it is meant to replace.
US Prescription-Drug Market Rebounds
The US market for prescription drugs grew better than expected in 2009, but growth is still below historical levels.
